Pharma Firms May Be Due A Refund Under UK Voluntary Price Scheme
Executive Summary
Companies that chose to stay in the UK’s voluntary pricing scheme (VPAS) could be entitled to a refund on their rebate payments, while those that have left may end up paying more.